"Specialties Our office specializes in the practice of Internal Medicine and focuses on providing health care to all members, emphasizing health awareness and prevention. Ages 18 and up, also conduct clinical research studies and are always looking for qualifying candidates to participate in them. History Established in 2003. Our office specializes in the practice of Internal Medicine and focuses on providing top notch HealthCare to all our patients. Emphasizing Health Awareness, Prevention and Maintenance to all patients eighteen years and older. We treat a variety of ailments with thorough medical care and the latest advancements in drug treatment and therapy. We at the office of Dr. Andres Patron also conduct Clinical Research Studies"

During the past decade, Andres Patron, D.O., P.A. conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Andres Patron, D.O., P.A." #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Andres Patron, D.O., P.A." are "Diabetes Mellitus, Type 2" (2 trials), "Dyslipidemia" (1 trials), "Hyperlipidemia" (1 trials), "Type 2 Diabetes" (1 trials) and "Type2 Diabetes" (1 trials). Many other conditions were trialed in "Andres Patron, D.O., P.A." in a lesser frequency.

Most popular intervention types in "Andres Patron, D.O., P.A." are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Bococizumab (PF-04950615; RN316)" (1 trials), "Empagliflozin (oral)" (1 trials), "Glimepiride (oral)" (1 trials) and "ITCA 650 (exenatide in DUROS)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Andres Patron, D.O., P.A." are 5 trials for "All" genders.

Currently, there are NaN active trials in "Andres Patron, D.O., P.A.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Andres Patron, D.O., P.A., undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Andres Patron, D.O., P.A., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".